CH
Christopher Hite sold $6.8M of RPRX stock
Christopher Hite, EVP & Chairman, Partnering of Royalty Pharma plc (RPRX), sold 100,000 shares of RPRX stock worth $6.8M, per an SEC Form 4 filed Nov 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 17, 2026, 1 day before it was made public.
RPRX has moved -1.4% since the trade date, from $68.68 to $67.72 (Nov 19, 2026 close).
- Traded
- Nov 17, 2026
- Disclosed
- Nov 18, 2026
- Filing delay
- 1 day
- Price since
- -1.4%
- Role
- EVP & Chairman, Partnering
- Source
- SEC Form 4